Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Tuberculosis

Free Subscription 09.03.2026 1 Antimicrob Agents Chemother 2 Clin Infect Dis 1 Eur J Clin Microbiol Infect Dis 2 Eur Respir J 4 Int J Tuberc Lung Dis 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Antimicrob Agents Chemother

1. MARANCHICK NF, Martyn-Dickens C, Enimil A, Yang H, et al
   Population pharmacokinetics of pyrazinamide and ethambutol in children with tuberculosis with or without HIV.
   Antimicrob Agents Chemother. 2026 Mar 2:e0090925. doi: 10.1128/aac.00909.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

2. YANG E, Van Brantegem P, Peloquin CA, Brooks MB, et al
   Pharmacokinetic and pharmacogenomic predictors of hepatotoxicity in the HIRIF trial for drug-susceptible tuberculosis.
   Clin Infect Dis. 2026 Mar 6:ciag141. doi: 10.1093.
   PubMed         Abstract available
   
   
3. CROWDER R, Thangakunam B, Andama A, Christopher DJ, et al
   Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein.
   Clin Infect Dis. 2026;82:e239-e247.
   PubMed         Abstract available
   
   

   
   Eur J Clin Microbiol Infect Dis

4. DUDNYK A, Tytarenko N, Andrada IR, Lytvyniuk O, et al
   Use of reverse dot blot hybridization DNA-array and targeted next-generation sequencing for the detection of drug resistance in patients with tuberculosis: a prospective diagnostic accuracy study.
   Eur J Clin Microbiol Infect Dis. 2026 Mar 6. doi: 10.1007/s10096-026-05451.
   PubMed        
   
   

   
   Eur Respir J

5. ALFFENAAR JC, Srivastava S, Centis R, Migliori GB, et al
   Do we need to revise the dose of isoniazid for the treatment of tuberculosis in children?
   Eur Respir J. 2026;67:2502263.
   PubMed        
   
   
6. 
   End-user global study to identify countries' challenges and solutions in the uptake and implementation of new tuberculosis treatment regimens.
   Eur Respir J. 2026;67:2502614.
   PubMed        
   
   

   
   Int J Tuberc Lung Dis

7. BAMULOBA M, Mukama SC, Nabukenya-Mudiope MG, Zawedde-Muyanja S, et al
   Casting light on TB: a community awareness, screening, testing, and treatment campaign.
   Int J Tuberc Lung Dis. 2026;30:93-99.
   PubMed         Abstract available
   
   
8. SOLE N, Prieto-Garcia R, Turu E, Millet JP, et al
   TB infection in the incarcerated population of Catalonia, Spain.
   Int J Tuberc Lung Dis. 2026;30:120-126.
   PubMed         Abstract available
   
   
9. KAMOLRATANAKUL S, Bhunyakarnjanarat T, Ariyanon W, Wilairatana P, et al
   Prognostic value of sputum HMGB1 in smear-negative and smear-positive pulmonary TB.
   Int J Tuberc Lung Dis. 2026;30:100-106.
   PubMed         Abstract available
   
   
10. WAKJIRA MK, Jerene D, Dano DH, Datiko DG, et al
    Providing comprehensive TB care among conflict-affected populations.
    Int J Tuberc Lung Dis. 2026;30:114-119.
    PubMed         Abstract available
    
    

    
    PLoS One

11. MPHOTHULO N, Loveday M
    Designing and evaluating the acceptability of a psychosocial and socioeconomic support package for people with drug-resistant tuberculosis in Johannesburg, South Africa.
    PLoS One. 2026;21:e0343154.
    PubMed         Abstract available
    
    
12. LI Y, Saad A, Feng Z, Ge S, et al
    Treatment of asymptomatic tuberculosis: Protocol for a systematic review of treatment strategies, regimens, and clinical outcomes.
    PLoS One. 2026;21:e0342929.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum